Antibiotic Exposure of Critically Ill Children at a Tertiary Care Paediatric Intensive Care Unit in Switzerland

Antibiotic overtreatment fosters multidrug-resistance that threatens healthcare systems worldwide as it increases patient morbidity and mortality. Contemporary data on antibiotic usage on tertiary care paediatric intensive care units for in- and external benchmarking are scarce. This was a single-ce...

Full description

Saved in:
Bibliographic Details
Main Authors: Anica Fenner (Author), Melanie Huber (Author), Verena Gotta (Author), Vera Jaeggi (Author), Luregn J. Schlapbach (Author), Philipp Baumann (Author)
Format: Book
Published: MDPI AG, 2024-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8dfa1f7f509141348858e3dbbcabf7c6
042 |a dc 
100 1 0 |a Anica Fenner  |e author 
700 1 0 |a Melanie Huber  |e author 
700 1 0 |a Verena Gotta  |e author 
700 1 0 |a Vera Jaeggi  |e author 
700 1 0 |a Luregn J. Schlapbach  |e author 
700 1 0 |a Philipp Baumann  |e author 
245 0 0 |a Antibiotic Exposure of Critically Ill Children at a Tertiary Care Paediatric Intensive Care Unit in Switzerland 
260 |b MDPI AG,   |c 2024-06-01T00:00:00Z. 
500 |a 10.3390/children11060731 
500 |a 2227-9067 
520 |a Antibiotic overtreatment fosters multidrug-resistance that threatens healthcare systems worldwide as it increases patient morbidity and mortality. Contemporary data on antibiotic usage on tertiary care paediatric intensive care units for in- and external benchmarking are scarce. This was a single-centre retrospective quality control study including all patients with antibiotic treatment during their hospitalization at a paediatric intensive care unit in the time period 2019-2021. Antibiotic treatment was calculated as days of therapy (DOT) per 100 patient days (DOT/100pd). Further, the variables PIM II score, length of stay in intensive care (LOS), gender, age, treatment year, reason for intensive care unit admission, and death were assessed. Two thousand and forty-one cases with a median age of 10 months [IQR 0-64] were included; 53.4% were male, and 4.5% of the included patients died. Median LOS was 2.73 days [0.07-5.90], and PIM II score was 1.98% [0.02-4.86]. Overall, the antibiotic exposure of critically ill children and adolescents was 59.8 DOT/100pd. During the study period, the antibiotic usage continuously increased (2019: 55.2 DOT/100pd; 2020: 59.8 DOT/100pd (+8.2%); 2021: 64.5 DOT/100pd (+8.0%)). The highest antibiotic exposure was found in the youngest patients (0-1 month old (72.7 DOT/100pd)), in patients who had a LOS of >2-7 days (65.1 DOT/100pd), those who had a renal diagnosis (98 DOT/100pd), and in case of death (91.5 DOT/100pd). Critically ill paediatric patients were moderately exposed to antibiotics compared to data from the previously published literature. The current underreporting of antimicrobial prescription data in this cohort calls for future studies for better internal and external benchmarking. 
546 |a EN 
690 |a neonate 
690 |a infant 
690 |a child 
690 |a children 
690 |a antibiotics 
690 |a antimicrobials 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Children, Vol 11, Iss 6, p 731 (2024) 
787 0 |n https://www.mdpi.com/2227-9067/11/6/731 
787 0 |n https://doaj.org/toc/2227-9067 
856 4 1 |u https://doaj.org/article/8dfa1f7f509141348858e3dbbcabf7c6  |z Connect to this object online.